Hoffmann-La Roche posts results of Phase III astegolimab trial in COPD
The study enrolled 1380 participants and completed primary data collection on June 24, 2025. Results were first posted on ClinicalTrials.gov on October 28, 2026.
Primary source
ClinicalTrials.gov results record, October 28, 2026
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Read the source: A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation